A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples